Literature DB >> 20162469

Progressive osteosclerosis and visceral calcification after cord blood transplantation.

Noboru Asada1, Shinichi Ishii, Kanako Wakahashi, Hiroki Kawano, Yuriko Kawamori, Shinichiro Nishikawa, Kentaro Minagawa, Atsuo Okamura, Manabu Shimoyama, Yoshio Katayama, Yoshitake Hayashi, Tomoo Itoh, Mitsune Tanimoto, Toshimitsu Matsui.   

Abstract

A 26-year-old woman, who successfully underwent umbilical cord blood transplantation for aplastic anemia 4 years previously, had suffered from hepatosplenic microabscesses caused by unidentifiable grocott stain-positive spores from immediately after the transplantation. At 51 months post-transplant, we attempted bone marrow biopsy from her posterior iliac crest, but failed to penetrate the cortical bone. X-ray of her spine and pelvis showed marked and diffuse osteosclerosis. Retrospective analysis of computed tomography revealed the gradual replacement of sternal, vertebral, and pelvic bone marrow with calcified tissues in addition to the dispersed calcification of the liver, spleen, and kidneys over the last 2 years. The bone mineral density of the lumbar spine had increased but not that of the femoral neck. Biomedical parameters for bone remodeling demonstrated enhanced bone formation as well as bone resorption and secondary hyperparathyroidism. Based on the past reports, we suggest that chronic fungal infection, which caused visceral calcification, induced the production of humoral factors for osteoblastic activation.

Entities:  

Mesh:

Year:  2010        PMID: 20162469     DOI: 10.1007/s12185-010-0524-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  11 in total

Review 1.  The infected liver: radiologic-pathologic correlation.

Authors:  Koenraad J Mortelé; Enrica Segatto; Pablo R Ros
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

Review 2.  Paget disease of bone.

Authors:  Tim Cundy; Mark Bolland
Journal:  Trends Endocrinol Metab       Date:  2008-08-06       Impact factor: 12.015

3.  Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-beta signal in osteoblastic cells in the patient with hepatitis C-associated osteosclerosis.

Authors:  H Kaji; J Naito; H Sowa; T Sugimoto; K Chihara
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-11       Impact factor: 2.949

Review 4.  A clinical and molecular overview of the human osteopetroses.

Authors:  W Balemans; L Van Wesenbeeck; W Van Hul
Journal:  Calcif Tissue Int       Date:  2005-11-16       Impact factor: 4.333

5.  Visceral and nodal calcification in patients with AIDS-related Pneumocystis carinii infection.

Authors:  D R Radin; E L Baker; E C Klatt; E J Balthazar; R B Jeffrey; A J Megibow; P W Ralls
Journal:  AJR Am J Roentgenol       Date:  1990-01       Impact factor: 3.959

6.  Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.

Authors:  S Khosla; A A Hassoun; B K Baker; F Liu; N N Zein; M P Whyte; C A Reasner; T B Nippoldt; R D Tiegs; R L Hintz; C A Conover
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

7.  Diffuse osteosclerosis in hairy cell leukemia.

Authors:  L A VanderMolen; W J Urba; D L Longo; J Lawrence; H Gralnick; R G Steis
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

8.  Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.

Authors:  Oliver Bock; Gero Loch; Ulrika Schade; Guntram Büsche; Reinhard Wasielewski; Birgitt Wiese; Hans Kreipe
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

Review 9.  Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology.

Authors:  Mark S Nanes
Journal:  Gene       Date:  2003-12-04       Impact factor: 3.688

10.  Severe, diffuse osteosclerosis: A new manifestation of transitional cell carcinoma of the urinary bladder.

Authors:  Y Liel; E Maor; S Ariad; M N Lowenthal
Journal:  Calcif Tissue Int       Date:  1998-12       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.